Stay updated on Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma
Sign up to get notified when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.

Latest updates to the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check65 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the study's purpose, inclusion and exclusion criteria, and details about the treatment for relapsed or refractory Natural Killer/T Cell Lymphoma. Additionally, the principal investigator's name has been deleted.SummaryDifference23%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.